Cervical tissue changes in women with miscarriage: A morphological and biochemical investigation

References

• Blohm F, Friden B, Milsom I. A prospective longitudinal population-based study of clinical miscarriage in an urban Swedish population. BJOG. 2008;115:176–83.
   PubMed Web of Science ®Google Scholar
• Nielsen S, Hahlin M, Platz-Christensen J. Randomised trial comparing expectant with medical management for first trimester miscarriages. Br J Obstet Gynaecol. 1999;106:804–7.
   PubMedGoogle Scholar
• Jurkovic D, Ross JA, Nicolaides KH. Expectant management of missed miscarriage. Br J Obstet Gynaecol. 1998;105:670–1.
   PubMedGoogle Scholar
• Nielsen S, Hahlin M, Platz-Christensen JJ. Unsuccessful treatment of missed abortion with a combination of an antiprogesterone and a prostaglandin E1 analogue. Br J Obstet Gynaecol. 1997;104:1094–6.
   PubMedGoogle Scholar
• Liggins GC. Cervical ripening as an inflammatory reaction. In: Ellwood DA & Anderson ABM, editors. The cervix in pregnancy and labour. Clinical and biochemical investigation. Edinburgh: Churchill Livingstone, 1981. pp. 1–9.
   Google Scholar
• Osmers RG, Blaser J, Kuhn W, Tschesche H. Interleukin-8 synthesis and the onset of labor. Obstet Gynecol. 1995;86:223–9.
   PubMed Web of Science ®Google Scholar
• Osmers R, Rath W, Adelmann-Grill BC, Fittkow C, Kuloczik M, Szeverenyi M, Origin of cervical collagenase during parturition. Am J Obstet Gynecol. 1992;166:1455–60.
   PubMed Web of Science ®Google Scholar
• von Hertzen H, Honkanen H, Piaggio G, Bartfai G, Erdenetungalag R, Gemzell-Danielsson K, WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy. BJOG. 2003;110:808–18.
   PubMed Web of Science ®Google Scholar
• Ngoc NT, Blum J, Westheimer E, Quan TT, Winikoff B. Medical treatment of missed abortion using misoprostol. Int J Gynaecol Obstet. 2004;87:138–42.
   PubMed Web of Science ®Google Scholar
• Hill LM, Guzick D, Fries J, Hixson J. Fetal loss rate after ultrasonically documented cardiac activity between 6 and 14 weeks, menstrual age. J Clin Ultrasound. 1991;19:221–3.
   PubMed Web of Science ®Google Scholar
• Ekerhovd E, Weijdegård B, Brännström M, Mattsby-Baltzer I, Norström A. Nitric oxide induced cervical ripening in the human: Involvement of cyclic guanosine monophosphate, prostaglandin F(2 alpha), and prostaglandin E(2). Am J Obstet Gynecol. 2002;186:745–50.
   PubMed Web of Science ®Google Scholar
• Radulovic NV, Ekerhovd E, Abrahamsson G, Norström A. Cervical priming in the first trimester: morphological and biochemical effects of misoprostol and isosorbide mononitrate. Acta Obstet Gynecol Scand. 2009;88:43–51.
   Web of Science ®Google Scholar
• Theobald PW, Rath W, Kuhnle H, Kuhn W. Histological and electron-microscopic examinations of collagenous connective tissue of the non-pregnant cervix, the pregnant cervix, and the pregnant prostaglandin-treated cervix. Arch Gynecol. 1982;231:241–5.
   PubMedGoogle Scholar
• Rådestad A, Thyberg J, Christensen NJ. Cervical ripening with mifepristone (RU 486) in first trimester abortion. An electron microscope study. Hum Reprod. 1993;8:1136–42.
   Google Scholar
• Chen R, Ning G, Zhao ML, Fleming MG, Diaz LA, Werb Z, Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest. 2001;108:1151–8.
   PubMed Web of Science ®Google Scholar
• Varayoud J, Ramos JG, Bosquiazzo VL, Munoz-de-Toro M, Luque EH. Mast cells degranulation affects angiogenesis in the rat uterine cervix during pregnancy. Reproduction. 2004;127:379–87.
   PubMed Web of Science ®Google Scholar
• Sennström MK, Brauner A, Lu Y, Granström LM, Malmström AL, Ekman GE. Interleukin-8 is a mediator of the final cervical ripening in humans. Eur J Obstet Gynecol Reprod Biol. 1997;74:89–92.
   PubMed Web of Science ®Google Scholar
• Hattori Y, Nakanishi T, Ozaki Y, Nozawa K, Sato T, Sugiura-Ogasawara M. Uterine cervical inflammatory cytokines, interleukin-6 and -8, as predictors of miscarriage in recurrent cases. Am J Reprod Immunol. 2007;58:350–7.
   PubMed Web of Science ®Google Scholar
• Curry TE Jr, Osteen KG. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev. 2003;24:428–65.
   PubMed Web of Science ®Google Scholar
• Watari M, Watari H, DiSanto ME, Chacko S, Shi GP, Strauss JF 3rd. Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells. Am J Pathol. 1999;154:1755–62.
   PubMed Web of Science ®Google Scholar
• Malmström E, Sennström M, Holmberg A, Frielingsdorf H, Eklund E, Malmström L, The importance of fibroblastsin remodelling of the human uterine cervix during pregnancy and parturition. Mol Hum Reprod. 2007;13:333–41.
   PubMedGoogle Scholar
• Sennström MB, Brauner A, Byström B, Malmström A, Ekman G. Matrix metalloproteinase-8 correlates with the cervical ripening process in humans. Acta Obstet Gynecol Scand. 2003;82:904–11.
   PubMed Web of Science ®Google Scholar
• Stygar D, Wang H, Vladic YS, Ekman G, Eriksson H, Sahlin L. Increased level of matrix metalloproteinases 2 and 9 in the ripening process of the human cervix. Biol Reprod. 2002;67:889–94.
   PubMedGoogle Scholar
• Aronsson A, Ulfgren AK, Stabi B, Stavreus-Evers A, Gemzell-Danielsson K. The effect of orally and vaginally administered misoprostol on inflammatory mediators and cervical ripening during early pregnancy. Contraception. 2005;72:33–9.
   PubMed Web of Science ®Google Scholar
• Olson MW, Toth M, Gervasi DC, Sado Y, Ninomiya Y, Fridman R. High affinity binding of latent matrix metalloproteinase-9 to the alpha2(IV) chain of collagen IV. J Biol Chem. 1998;273:10672–81.
   Google Scholar
• Tarlton JF, Vickery CJ, Leaper DJ, Bailey AJ. Postsurgical wound progression monitored by temporal changes in the expression of matrix metalloproteinase-9. Br J Dermatol. 1997;137:506–16.
   Web of Science ®Google Scholar